114 related articles for article (PubMed ID: 17923592)
21. Hydrocortisone for severe community acquired pneumonia in ICU.
Drug Ther Bull; 2023 Dec; 62(1):3. PubMed ID: 37879879
[No Abstract] [Full Text] [Related]
22. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine in Argentinean Adults.
Rey-Ares L; Averin A; Mac Mullen M; Hariharan D; Atwood M; Carballo C; Huang L
Infect Dis Ther; 2024 Jun; 13(6):1235-1251. PubMed ID: 38700655
[TBL] [Abstract][Full Text] [Related]
23. Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine Among US Children with Underlying Medical Conditions.
Rozenbaum MH; Chilson E; Farkouh R; Huang L; Cane A; Arguedas A; Tort MJ; Snow V; Averin A; Weycker D; Hariharan D; Atwood M
Infect Dis Ther; 2024 Apr; 13(4):745-760. PubMed ID: 38491269
[TBL] [Abstract][Full Text] [Related]
24. The risk factors and predictive modeling of mortality in patients with mental disorders combined with severe pneumonia.
Li Y; Zhou W; Wang H; Yang J; Li X
Front Psychiatry; 2023; 14():1300740. PubMed ID: 38274425
[TBL] [Abstract][Full Text] [Related]
25. A Multicenter Evaluation of Overall Susceptibility and Antimicrobial Resistance Among Streptococcus pneumoniae Isolates.
Kulkarni N; Routray A; Taur S
Cureus; 2023 Jul; 15(7):e41984. PubMed ID: 37593286
[TBL] [Abstract][Full Text] [Related]
26. Hospitalisation outcomes in pneumococcal-vaccinated
Venkitakrishnan R; Vijay A; Augustine J; Ramachandran D; Cleetus M; Nirmal AS; John S
ERJ Open Res; 2023 Jul; 9(3):. PubMed ID: 37143841
[TBL] [Abstract][Full Text] [Related]
27. Healthcare Providers' Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards.
Alshehri A; Ahmed M; Bagazi D; Alghamdi A
Vaccines (Basel); 2023 Feb; 11(2):. PubMed ID: 36851308
[TBL] [Abstract][Full Text] [Related]
28. Increasing pneumococcal vaccine uptake in older adults: a scoping review of interventions in high-income countries.
Kirubarajan A; Lynch M; Nasreen S; Gebretekle GB; Fadel SA; Crowcroft NS; Allin S
BMC Geriatr; 2023 Jan; 23(1):2. PubMed ID: 36593474
[TBL] [Abstract][Full Text] [Related]
29. Clinical practice guidelines 2019: Indian consensus-based recommendations on pneumococcal vaccination for adults.
Dhar R; Ghoshal AG; Guleria R; Sharma S; Kulkarni T; Swarnakar R; Samaria JK; Chaudhary S; Gaur SN; Christopher DJ; Singh V; Abraham G; Sarkar A; Mukhopadhyay A; Panda J; Swaminathan S; Nene A; Krishnan S; Shahi PK; Sarangdhar N; Mishra N; Chowdury SR; Halder I; Katiyar SK; Jain VK; Chawla R; Koul PA
Lung India; 2020 Aug; 37(Supplement):S19-S29. PubMed ID: 32830790
[TBL] [Abstract][Full Text] [Related]
30. Community-acquired bacterial pneumonia in adults: An update.
Eshwara VK; Mukhopadhyay C; Rello J
Indian J Med Res; 2020 Apr; 151(4):287-302. PubMed ID: 32461392
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for pneumonia and influenza hospitalizations in long-term care facility residents: a retrospective cohort study.
Moyo P; Zullo AR; McConeghy KW; Bosco E; van Aalst R; Chit A; Gravenstein S
BMC Geriatr; 2020 Feb; 20(1):47. PubMed ID: 32041538
[TBL] [Abstract][Full Text] [Related]
32. Pneumococcal disease burden from an Indian perspective: Need for its prevention in pulmonology practice.
Koul PA; Chaudhari S; Chokhani R; Christopher D; Dhar R; Doshi K; Ghoshal A; Luhadiya SK; Mahashur A; Mehta R; Nene A; Rahman M; Swarnakar R
Lung India; 2019; 36(3):216-225. PubMed ID: 31031342
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of the 13-valent pneumococcal conjugate vaccine in adults in Portugal versus "no vaccination" and versus vaccination with the 23-valent pneumococcal polysaccharide vaccine.
Gouveia M; Jesus G; Inês M; Costa J; Borges M
Hum Vaccin Immunother; 2019; 15(4):850-858. PubMed ID: 30633615
[TBL] [Abstract][Full Text] [Related]
34. Ten-year trends in intensive care admissions for respiratory infections in the elderly.
Laporte L; Hermetet C; Jouan Y; Gaborit C; Rouve E; Shea KM; Si-Tahar M; Dequin PF; Grammatico-Guillon L; Guillon A
Ann Intensive Care; 2018 Aug; 8(1):84. PubMed ID: 30112650
[TBL] [Abstract][Full Text] [Related]
35. Estimating the cost-effectiveness of a sequential pneumococcal vaccination program for adults in Germany.
Kuchenbecker U; Chase D; Reichert A; Schiffner-Rohe J; Atwood M
PLoS One; 2018; 13(5):e0197905. PubMed ID: 29795647
[TBL] [Abstract][Full Text] [Related]
36. Pneumonia and Streptococcus pneumoniae vaccine.
Kim GL; Seon SH; Rhee DK
Arch Pharm Res; 2017 Aug; 40(8):885-893. PubMed ID: 28735461
[TBL] [Abstract][Full Text] [Related]
37. Pneumococcal and influenza vaccination status of hospitalized adults with community acquired pneumonia and the effects of vaccination on clinical presentation.
Demirdogen Cetinoglu E; Uzaslan E; Sayıner A; Cilli A; Kılınc O; Sakar Coskun A; Hazar A; Kokturk N; Filiz A; Polatli M;
Hum Vaccin Immunother; 2017 Sep; 13(9):2072-2077. PubMed ID: 28708954
[TBL] [Abstract][Full Text] [Related]
38. How and when to use common biomarkers in community-acquired pneumonia.
Shaddock EJ
Pneumonia (Nathan); 2016; 8():17. PubMed ID: 28702296
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of 23-valent pneumococcal polysaccharide vaccination in preventing community-acquired pneumonia hospitalization and severe outcomes in the elderly in Spain.
Domínguez À; Soldevila N; Toledo D; Torner N; Force L; Pérez MJ; Martín V; Rodríguez-Rojas L; Astray J; Egurrola M; Sanz F; Castilla J;
PLoS One; 2017; 12(2):e0171943. PubMed ID: 28187206
[TBL] [Abstract][Full Text] [Related]
40. Community-acquired pneumonia.
Prina E; Ranzani OT; Torres A
Lancet; 2015 Sep; 386(9998):1097-108. PubMed ID: 26277247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
